Results 121 to 130 of about 905,435 (191)

Rising Incidence of New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018-2023. [PDF]

open access: yesOpen Forum Infect Dis
Duffy N   +30 more
europepmc   +1 more source

Development of novel phosphonic acid-type metallo-β-lactamase inhibitors

open access: yes
The Global Antibiotic Research & Development Partnership (GARDP) estimates that antibiotic resistance claims one life in every 6 seconds. Antibiotic resistance is already associated with 5 million deaths annually, and this number continues to rise. A
Rosenström, Ulrika,   +2 more
core  

Structure based drug design: the discovery of novel inhibitors active against New Delhi Metallo-β-lactamase-1

open access: yes, 2017
Background. The emergence of bacterial strains resistant to available antibiotic armamentarium is nowadays a pressing issue in clinical therapy. Among the several mechanisms of bacterial resistance, the rapid evolution and spread of carbapenemases, β ...
Cross, Simon   +7 more
core  

Management of metallo-β-lactamase-producing Enterobacterales infections: a modified Delphi study. [PDF]

open access: yesJAC Antimicrob Resist
Carmeli Y   +13 more
europepmc   +1 more source

Chelate-conjugated β-lactams resensitize metallo-β-lactamase IMP-1-producing gram-negative bacteria against carbapenem antibiotics. [PDF]

open access: yesMicrobiol Spectr
Toyomoto T   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy